RxDoctor Payments DataLook up a doctor →

Chester Robachinski

Psychiatry · Seattle, WANPI 1285697573

Payments from drug & device makers

$1,131,106in general payments, 2019–2025

Across 1,856 payments — averaging $609.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$428K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$224K
  • AbbVie$128K
  • Alkermes, Inc.$96K
  • Vanda Pharmaceuticals Inc.$91K
  • Axsome Therapeutics, Inc.$75K
  • plus $89K from 16 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson618$427,966
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)306$223,565
AbbVie(2 entities)304$127,699
Alkermes, Inc.176$96,314
Vanda Pharmaceuticals Inc.130$90,999
Axsome Therapeutics, Inc.100$75,318
Neurocrine Biosciences, Inc.74$34,079
Otsuka Pharmaceutical Development & Commercialization, Inc.37$19,231
Janssen Scientific Affairs, LLC18$19,199
Sunovion Pharmaceuticals Inc.29$5,728
Otsuka America Pharmaceutical, Inc.27$5,073
Eisai Inc.13$4,901
Jazz Pharmaceuticals Inc.8$379
Tris Pharma Inc3$226
Corium, LLC3$130
Gilead1$113
Viiv Healthcare Company2$52
Lundbeck LLC2$39
Shire North American Group Inc2$37
Sage Therapeutics, LLC1$24
Biogen1$19
Sumitomo Pharma America, Inc.1$16

How this compares

$1,131,106 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington →

Other psychiatry in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →